ClinicalTrials.gg
RecruitingNCT06910176CANDELSUpdated Sep 26, 2025

Confirming And Notifying Death

An observational study in Death Records, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-26.

Sponsored by University Hospital, Strasbourg, France · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 2 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 51 studies in Death with a site in France — 14 open to participants now, 15 under way, 3 of them phase 3. Death · France.

Planned enrollment
33rd of 37
20 · median 354
Started
2024
with 5 others
Observational
38 of 51
10 open now
Primary completion
2025-12
later than 2 of 14 live
Registered
43rd of 51
by date
Lead sponsor
6 of 51
University Hospital, Strasbourg, France

Among the 51 studies in Death with a site in France, this one is the 33rd largest by planned enrollment of the 37 observational ones that give a count, is one of 6 that started in 2024, is one of 38 observational ones, reaches primary completion later than 2 of the 14 other live ones, and was the 43rd registered.

Death

457 studies on the registry are indexed under Death; 85 are open to participants now.

Browse Death studies →

Open to participants now

14 of the 51 studies in Death with a site in France are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 58 Death studies recruiting now, 43 (74%) set no upper age limit and 8 (14%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies in Death with a site in France, or all of them as a file.
02

Study summary

Most physicians are confronted with the death of patients during their practice, often as early as residency. It is their legal responsibility to certify a patient's death, as well as often to notify their loved ones.

Yet, these duties currently receive little or no specific training during the various cycles of medical education.

This task is not easy, however, and young professionals experience it with difficulty. Literature data show that residents are confronted with death late in their medical education and that they are insufficiently prepared when they have to perform their first death certificate. Indeed, residents report significantly correlated practical and emotional difficulties. These difficulties are notably linked to a feeling of lack of preparation through theoretical courses, a lack of familiarity with administrative procedures, and insufficient mastery of communicating with families. The highlighting of these difficulties and the desire for appropriate and respectful care for the deceased and their families, for whom the moment of announcement influences the experience of grief, call for an improvement in teaching on these topics. It is in this sense that the project was born to explore whether the creation of training, before their independent exposure to death and its announcement, i.e. at the end of the second cycle, was relevant. A prerequisite for this type of training project is indeed to question the acceptability of such an approach by students.

03

Conditions studied

  • Death Records

Browse trials for

Keywords

  • Notifying Death
  • Death Records
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Student having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024),

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DFASM3 student,
  • At the Faculty of Medicine of Strasbourg, France, for the 2023-2024 academic year,
  • Having taken the national ECOS (thus becoming an intern at the start of the following academic year in November 2024),
  • Aged 18 years or older,
  • Not opposed to participating in the study.
  • Not having completed an internship in specialized palliative care facilities

Exclusion criteria

Exclusion Criteria:

  • Refused to participate in the study.
  • Not having taken the national ECOS.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To assess the acceptability of training in death certification and death notification to relatives by DFASM3 students in Strasbourg.

    Time frame: At 6 months

07

Study locations

1 of 1 sites recruiting
  • Service de soins Palliatifs - CHU de Strasbourg - France
    Strasbourg, 67091, France
    Recruiting
    • Catherine CHEVALIER-LAMOUILLE, MD · Contactcatherine.lamouille@chru-strasbourg.fr · 33 3 88 11 65 86
    • Catherine CHEVALIER-LAMOUILLE, MD · Principal investigator
    • Daphné PRIEUR-DREVON, MD · Principal investigator
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2024 (actual). Primary completion is estimated for Dec 2025, 14 months after the start.

Of 85 non-industry observational studies under Death, half reached primary completion within 69 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 245. This study's planned 14 months is below that.

Counting every sponsor, half of 88 studies reached it within 69 months; a quarter within 23 and three quarters within 245.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2025
First posted
Apr 4, 2025
StartActual
Oct 10, 2024
Primary completionEst.
Dec 10, 2025
CompletionEst.
Dec 10, 2025
Last update
Sep 26, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06910176
Responsible party
Sponsor
First posted
Apr 4, 2025
Start date
Oct 10, 2024
Primary completion
Dec 10, 2025 (estimated)
Completion
Dec 10, 2025 (estimated)
Last update
Sep 26, 2025

Study contacts

Catherine CHEVALIER-LAMOUILLE, MD
Contact
catherine.lamouille@chru-strasbourg.fr
33 3 88 11 65 86

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion